ICU Medical Pre-Tax Profit Margin 2012-2026 | ICUI
ICU Medical pre-tax profit margin from 2012 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| ICU Medical Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2026-06-30 | $2.16B | 0 | 0.00% |
| 2026-03-31 | $2.16B | $0.01B | 0.51% |
| 2025-12-31 | $2.23B | $0.00B | 0.18% |
| 2025-09-30 | $2.32B | $0.03B | 1.21% |
| 2025-06-30 | $2.37B | $0.01B | 0.55% |
| 2025-03-31 | $2.42B | $-0.04B | -1.69% |
| 2024-12-31 | $2.38B | $-0.07B | -2.81% |
| 2024-09-30 | $2.34B | $-0.11B | -4.79% |
| 2024-06-30 | $2.30B | $-0.10B | -4.30% |
| 2024-03-31 | $2.26B | $-0.10B | -4.52% |
| 2023-12-31 | $2.26B | $-0.08B | -3.45% |
| 2023-09-30 | $2.25B | $-0.06B | -2.76% |
| 2023-06-30 | $2.29B | $-0.08B | -3.40% |
| 2023-03-31 | $2.31B | $-0.07B | -3.12% |
| 2022-12-31 | $2.28B | $-0.11B | -5.00% |
| 2022-09-30 | $2.04B | $-0.07B | -3.43% |
| 2022-06-30 | $1.78B | $-0.01B | -0.62% |
| 2022-03-31 | $1.54B | $0.04B | 2.66% |
| 2021-12-31 | $1.32B | $0.12B | 9.34% |
| 2021-09-30 | $1.30B | $0.13B | 10.03% |
| 2021-06-30 | $1.28B | $0.12B | 9.23% |
| 2021-03-31 | $1.26B | $0.10B | 8.25% |
| 2020-12-31 | $1.27B | $0.10B | 7.63% |
| 2020-09-30 | $1.27B | $0.09B | 6.95% |
| 2020-06-30 | $1.26B | $0.10B | 7.57% |
| 2020-03-31 | $1.26B | $0.10B | 8.07% |
| 2019-12-31 | $1.27B | $0.12B | 9.08% |
| 2019-09-30 | $1.29B | $0.08B | 6.36% |
| 2019-06-30 | $1.31B | $0.05B | 3.82% |
| 2019-03-31 | $1.36B | $0.05B | 3.83% |
| 2018-12-31 | $1.40B | $0.02B | 1.64% |
| 2018-09-30 | $1.43B | $0.08B | 5.25% |
| 2018-06-30 | $1.45B | $0.08B | 5.47% |
| 2018-03-31 | $1.42B | $0.01B | 0.71% |
| 2017-12-31 | $1.29B | $0.05B | 4.02% |
| 2017-09-30 | $1.02B | $0.03B | 2.55% |
| 2017-06-30 | $0.77B | $0.04B | 5.69% |
| 2017-03-31 | $0.54B | $0.11B | 19.89% |
| 2016-12-31 | $0.38B | $0.09B | 22.37% |
| 2016-09-30 | $0.37B | $0.08B | 22.46% |
| 2016-06-30 | $0.36B | $0.09B | 23.69% |
| 2016-03-31 | $0.35B | $0.08B | 23.71% |
| 2015-12-31 | $0.34B | $0.07B | 20.53% |
| 2015-09-30 | $0.33B | $0.07B | 20.85% |
| 2015-06-30 | $0.32B | $0.05B | 16.46% |
| 2015-03-31 | $0.32B | $0.04B | 12.93% |
| 2014-12-31 | $0.31B | $0.04B | 12.94% |
| 2014-09-30 | $0.31B | $0.04B | 13.68% |
| 2014-06-30 | $0.31B | $0.05B | 15.65% |
| 2014-03-31 | $0.31B | $0.05B | 16.29% |
| 2013-12-31 | $0.31B | $0.05B | 16.88% |
| 2013-09-30 | $0.32B | $0.06B | 18.18% |
| 2013-06-30 | $0.32B | $0.06B | 18.93% |
| 2013-03-31 | $0.32B | $0.06B | 20.00% |
| 2012-12-31 | $0.32B | $0.06B | 19.87% |
| 2012-09-30 | $0.31B | $0.07B | 22.58% |
| 2012-06-30 | $0.31B | $0.07B | 21.31% |
| 2012-03-31 | $0.31B | $0.07B | 21.24% |
| 2011-12-31 | $0.30B | $0.07B | 21.93% |
| 2011-09-30 | $0.30B | $0.06B | 18.39% |
| 2011-06-30 | $0.30B | $0.06B | 18.73% |
| 2011-03-31 | $0.29B | $0.05B | 18.62% |
| 2010-12-31 | $0.28B | $0.05B | 16.96% |
| 2010-09-30 | $0.28B | $0.04B | 15.22% |
| 2010-06-30 | $0.25B | $0.04B | 14.17% |
| 2010-03-31 | $0.24B | $0.03B | 13.87% |
| 2009-12-31 | $0.23B | $0.04B | 16.23% |
| 2009-09-30 | $0.22B | $0.04B | 19.27% |
| 2009-06-30 | $0.22B | $0.05B | 21.00% |
| 2009-03-31 | $0.22B | $0.04B | 20.47% |
| 2008-12-31 | $0.21B | $0.04B | 17.96% |
| 2008-09-30 | $0.20B | $0.03B | 15.90% |
| 2008-06-30 | $0.19B | $0.03B | 14.05% |
| 2008-03-31 | $0.19B | $0.02B | 12.43% |
| 2007-12-31 | $0.19B | $0.03B | 17.99% |
| 2007-09-30 | $0.20B | $0.03B | 16.33% |
| 2007-06-30 | $0.20B | $0.04B | 17.50% |
| 2007-03-31 | $0.20B | $0.04B | 20.30% |
| 2006-12-31 | $0.20B | $0.04B | 17.82% |
| 2006-09-30 | $0.19B | $0.04B | 19.79% |
| 2006-06-30 | $0.19B | $0.04B | 19.47% |
| 2006-03-31 | $0.18B | $0.03B | 18.89% |
| 2005-12-31 | $0.16B | $0.03B | 19.62% |
| 2005-09-30 | $0.13B | $0.02B | 15.38% |
| 2005-06-30 | $0.10B | $0.01B | 9.09% |
| 2005-03-31 | $0.08B | $0.01B | 8.75% |
| 2004-12-31 | $0.08B | $0.01B | 9.33% |
| 2004-09-30 | $0.09B | $0.02B | 23.33% |
| 2004-06-30 | $0.10B | $0.03B | 30.00% |
| 2004-03-31 | $0.10B | $0.03B | 31.31% |
| 2003-12-31 | $0.11B | $0.04B | 32.41% |
| 2003-09-30 | $0.10B | $0.03B | 33.33% |
| 2003-06-30 | $0.10B | $0.03B | 35.42% |
| 2003-03-31 | $0.10B | $0.04B | 36.73% |
| 2002-12-31 | $0.09B | $0.03B | 36.36% |
| 2002-09-30 | $0.09B | $0.03B | 34.12% |
| 2002-06-30 | $0.08B | $0.03B | 33.33% |
| 2002-03-31 | $0.08B | $0.03B | 33.33% |
| 2001-12-31 | $0.07B | $0.02B | 34.78% |
| 2001-09-30 | $0.07B | $0.02B | 35.38% |
| 2001-06-30 | $0.06B | $0.02B | 34.43% |
| 2001-03-31 | $0.06B | $0.02B | 34.48% |
| 2000-12-31 | $0.06B | $0.02B | 33.33% |
| 2000-09-30 | $0.05B | $0.02B | 33.96% |
| 2000-06-30 | $0.05B | $0.02B | 34.62% |
| 2000-03-31 | $0.05B | $0.02B | 34.00% |
| 1999-12-31 | $0.05B | $0.02B | 31.91% |
| 1999-09-30 | $0.04B | $0.01B | 29.55% |
| 1999-06-30 | $0.04B | $0.01B | 30.23% |
| 1999-03-31 | $0.04B | $0.01B | 29.27% |
| 1998-12-31 | $0.04B | $0.01B | 30.00% |
| 1998-09-30 | $0.04B | $0.02B | 46.15% |
| 1998-06-30 | $0.04B | $0.02B | 40.54% |
| 1998-03-31 | $0.03B | $0.01B | 41.18% |
| 1997-12-31 | $0.03B | $0.01B | 41.94% |
| 1997-09-30 | $0.03B | $0.01B | 35.71% |
| 1997-06-30 | $0.03B | $0.01B | 46.15% |
| 1997-03-31 | $0.03B | $0.01B | 48.00% |
| 1996-12-31 | $0.02B | $0.02B | 66.67% |
| 1996-09-30 | $0.02B | $0.01B | 52.17% |
| 1996-06-30 | $0.02B | $0.01B | 50.00% |
| 1996-03-31 | $0.02B | $0.01B | 45.45% |
| 1995-12-31 | $0.02B | $0.01B | 23.81% |
| 1995-09-30 | $0.02B | $0.00B | 19.05% |
| 1995-06-30 | $0.02B | $0.00B | 15.79% |
| 1995-03-31 | $0.02B | $0.00B | 17.65% |
| 1994-12-31 | $0.02B | $0.00B | 25.00% |
| 1994-09-30 | $0.02B | $0.00B | 26.67% |
| 1994-06-30 | $0.01B | $0.01B | 35.71% |
| 1994-03-31 | $0.01B | $0.01B | 41.67% |
| 1993-12-31 | $0.01B | $0.00B | 36.36% |
| 1993-09-30 | $0.01B | $0.00B | 40.00% |
| 1993-06-30 | $0.01B | $0.00B | 36.36% |
| 1993-03-31 | $0.01B | $0.00B | 36.36% |
| 1992-12-31 | $0.01B | $0.00B | 40.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.822B | $2.231B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.897B | 19.43 |
| Medtronic (MDT) | Ireland | $118.666B | 16.22 |
| Stryker (SYK) | United States | $107.450B | 20.08 |
| EssilorLuxottica (ESLOY) | France | $75.078B | 0.00 |
| Boston Scientific (BSX) | United States | $63.114B | 13.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.379B | 0.00 |
| Agilent Technologies (A) | United States | $44.077B | 25.80 |
| Medline (MDLN) | United States | $42.228B | 0.00 |
| ResMed (RMD) | United States | $32.950B | 20.45 |
| GE HealthCare Technologies (GEHC) | United States | $29.109B | 13.92 |
| Koninklijke Philips (PHG) | Netherlands | $24.258B | 12.92 |
| Terumo (TRUMY) | Japan | $21.654B | 20.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.977B | 11.11 |
| Baxter (BAX) | United States | $11.901B | 11.23 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.666B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.225B | 41.21 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Insulet (PODD) | United States | $9.817B | 24.11 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.579B | 20.24 |
| BillionToOne (BLLN) | United States | $5.222B | 158.10 |
| Raia Drogasil SA - (RADLY) | Brazil | $5.122B | 0.00 |
| Haemonetics (HAE) | United States | $4.895B | 21.48 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $3.805B | 16.12 |
| AtriCure (ATRC) | United States | $3.007B | 257.04 |
| Neogen (NEOG) | United States | $2.798B | 49.35 |
| Curaleaf Holdings (CURLF) | United States | $2.396B | 0.00 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.288B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.243B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.201B | 10.51 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.888B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.871B | 5.39 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 29.22 |
| BioLife Solutions (BLFS) | United States | $1.803B | 230.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.450B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.436B | 15.31 |
| Phibro Animal Health (PAHC) | United States | $1.399B | 10.73 |
| Omeros (OMER) | United States | $1.336B | 6.76 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.107B | 0.00 |
| CeriBell (CBLL) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.836B | 11.63 |
| AdaptHealth (AHCO) | United States | $0.785B | 16.46 |
| VAREX IMAGING (VREX) | United States | $0.781B | 17.17 |
| QuidelOrtho (QDEL) | United States | $0.761B | 8.21 |
| Glass House Brands (GLAS) | United States | $0.749B | 0.00 |
| Valneva SE (VALN) | France | $0.623B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.548B | 0.00 |
| Brainsway (BWAY) | Israel | $0.544B | 30.75 |
| Vireo Growth (VREOF) | United States | $0.540B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.537B | 0.00 |
| Cerus (CERS) | United States | $0.536B | 0.00 |
| Evolus (EOLS) | United States | $0.529B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.446B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| SNDL (SNDL) | Canada | $0.350B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.341B | 24.86 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.302B | 0.00 |
| MacroGenics (MGNX) | United States | $0.263B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 13.28 |
| OraSure Technologies (OSUR) | United States | $0.241B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 22.62 |
| High Tide (HITI) | Canada | $0.236B | 53.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.201B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.191B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.151B | 0.00 |
| Quanterix (QTRX) | United States | $0.148B | 0.00 |
| Apyx Medical (APYX) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.091B | 124.75 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.77 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.079B | 4.48 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.049B | 3.97 |
| Nephros (NEPH) | United States | $0.046B | 38.46 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.036B | 17.21 |
| United-Guardian (UG) | United States | $0.033B | 13.39 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.023B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |